We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+6.39%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$9.65B
AUM Growth
+$414M
(+4.5%)
Cap. Flow
+$77.2M
Cap. Flow
% of AUM
0.8%
Top 10 Holdings %
Top 10 Hldgs %
20.18%
Holding
1,150
New
121
Increased
363
Reduced
495
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$53.4M |
| 2 |
Occidental Petroleum
OXY
|
+$38M |
| 3 |
Capital One
COF
|
+$36.7M |
| 4 |
Elevance Health
ELV
|
+$27.1M |
| 5 |
Kroger
KR
|
+$20.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Align Technology
ALGN
|
+$43.2M |
| 2 |
Microsoft
MSFT
|
+$36.6M |
| 3 |
Qualcomm
QCOM
|
+$34.8M |
| 4 |
Mastercard
MA
|
+$33.6M |
| 5 |
Merck
MRK
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.04% |
| 2 | Healthcare | 14.84% |
| 3 | Consumer Discretionary | 14.57% |
| 4 | Financials | 13.21% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Post Holdings
POST
$4.27B
| $12.4M | 0.13% |
220,367
+24,482
| +12% | +$1.4M |
|
177
Travere Therapeutics
TVTX
$5.2B
| $12.4M | 0.13% |
669,375
-14,871
| -2% | -$289K |
|
178
Green Plains
GPRE
$1.15B
| $12.3M | 0.13% |
796,233
-74,376
| -9% | -$1.02M |
|
179
Corcept Therapeutics
CORT
$10.1B
| $12.3M | 0.13% |
704,024
-165,376
| -19% | -$2.64M |
|
180
Stewart Information Services
STC
$2.11B
| $12.2M | 0.13% |
277,964
-11,329
| -4% | -$458K |
|
|
CADE
181
DELISTED
Cadence Bancorporation
CADE
| $12.1M | 0.13% |
1,409,003
-166,598
| -11% | -$1.44M |
|
182
Dow Inc
DOW
$20.8B
| $12M | 0.12% |
255,190
+16,779
| +7% | +$754K |
|
183
Boston Beer
SAM
$1.93B
| $12M | 0.12% |
13,586
+1,533
| +13% | +$1.21M |
|
184
Interactive Brokers
IBKR
$40.5B
| $11.9M | 0.12% |
989,048
+669,440
| +209% | +$8.35M |
|
185
Stepan Co
SCL
$1.32B
| $11.8M | 0.12% |
108,693
-8,869
| -8% | -$970K |
|
186
Pitney Bowes
PBI
$2.41B
| $11.8M | 0.12% |
2,221,741
-1,893,917
| -46% | -$8.74M |
|
|
DCH
187
Dauch Corp
DCH
$1.33B
| $11.8M | 0.12% |
2,040,590
+85,803
| +4% | +$614K |
|
188
Verizon
VZ
$201B
| $11.8M | 0.12% |
197,809
-99,535
| -33% | -$5.78M |
|
189
Enanta Pharmaceuticals
ENTA
$367M
| $11.7M | 0.12% |
256,064
-8,197
| -3% | -$397K |
|
|
VSTO
190
DELISTED
Vista Outdoor Inc.
VSTO
| $11.7M | 0.12% |
578,619
-419,001
| -42% | -$7.68M |
|
|
CERN
191
DELISTED
Cerner Corp
CERN
| $11.5M | 0.12% |
159,002
+2,104
| +1% | +$150K |
|
192
Supernus Pharmaceuticals
SUPN
$2.77B
| $11.4M | 0.12% |
547,298
+90,717
| +20% | +$2.06M |
|
|
ACC
193
DELISTED
American Campus Communities, Inc.
ACC
| $11.4M | 0.12% |
325,650
-93,409
| -22% | -$3.22M |
|
194
ScottsMiracle-Gro
SMG
$4.25B
| $11.3M | 0.12% |
+73,838
| New | +$11.4M |
|
195
American Financial Group
AFG
$12B
| $11.1M | 0.12% |
166,450
+153,352
| +1,171% | +$9.88M |
|
196
Unum
UNM
$14B
| $11.1M | 0.11% |
657,165
+271,235
| +70% | +$4.82M |
|
197
Spectrum Brands
SPB
$2.08B
| $11.1M | 0.11% |
+193,414
| New | +$10.6M |
|
|
198
Merck
MRK
$326B
| $11M | 0.11% |
138,897
-426,431
| -75% | -$33.4M |
|
199
Super Micro Computer
SMCI
$18.4B
| $10.9M | 0.11% |
4,143,780
-1,380,140
| -25% | -$3.77M |
|
200
SLM Corp
SLM
$4.74B
| $10.9M | 0.11% |
1,350,216
-1,265,417
| -48% | -$9.25M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2020 Portfolio in Review
As of Q3 2020, Jacobs Levy Equity Management held 1,150 positions worth $9.65B, up 4.5% from $9.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jacobs Levy Equity Management's Q3 2020 filing shows 121 new, 363 increased, 495 reduced and 137 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M. The largest sale was Align Technology, an estimated $43.2M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q3 2020 buy was BioMarin Pharmaceuticals: 191,373 shares worth $14.6M.
- Jacobs Levy Equity Management added most to Lowe's Companies in Q3 2020, an estimated $53.4M increase.
- Jacobs Levy Equity Management's biggest Q3 2020 reduction was Align Technology, cutting an estimated $43.2M.
- Jacobs Levy Equity Management fully exited Cloudera, Inc. in Q3 2020, selling an estimated $17.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 20% of its $9.65B portfolio in Q3 2020.
- Jacobs Levy Equity Management opened 121 new positions and closed 137 in Q3 2020.
- Jacobs Levy Equity Management's portfolio value rose 4.5% quarter-over-quarter to $9.65B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2020, filed 16 Nov 2020.